SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Prefilled Syringe, 12y+
- RxCUI
- 2722598
- RxNorm name
- SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Prefilled Syringe, 12y+
- Display name
- SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Prefilled Syringe, 12y+
- Full name
- SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Prefilled Syringe, 12y+
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:56
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125742 | Comirnaty | COVID-19 Vaccine, mRNA | 351(a) | Disc | 2026-08-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 48c86164-de07-4041-b9dc-f2b5744714e5 | SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Prefilled Syringe, 12y+ [PSN] · 0.3 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 OMICRON (LP.8.1) 0.1 MG/ML Prefilled Syringe [SCD] · SARS-CoV-2 (COVID-19) vaccine 2025-2026, mRNA-BNT162b2 OMICRON (LP.8.1) 0.3 ML Prefilled Syringe, 12y+ [SY] | 3 | 20 | These highlights do not include all the information needed to use COMIRNATY safely and effectively. See full prescribing information for COMIRNATY. COMIRNATY ® (COVID-19 Vaccine, mRNA) injectable suspension, for intramuscular use 2025-2026 Formula Initial U.S. Approval: 2021 | 20260303 |